Huntsman Cancer Institute becomes first Mediso Preclinical Imaging Center of Excellence in North America

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

HUNTSMAN CANCER INSTITUTE became the first Mediso Preclinical Imaging Center of Excellence in North America.

Two multi-modality nanoScan in vivo preclinical imaging systems have been installed at HCI: a nanoScan PET/MRI, combining positron emission tomography and magnetic resonance imaging techniques in one integrated system, and a nanoScan SPECT/CT, combining single photon emission tomography and x-ray computed tomography in one combined system.

Both systems integrate four imaging modalities without any compromise in image quality, performance and ease of use.

HCI provides a unique combination with the possibility to perform quantitative preclinical imaging covering four modalities – PET, SPECT, MRI and CT.

The researchers are able to select any combination of the modalities to interrogate a wide range of biological questions by using the common building blocks developed by Mediso, including the Nucline acquisition framework and the MultiCell animal handling and monitoring system.

Table of Contents

YOU MAY BE INTERESTED IN

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges.  Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login